the drawbacks of these traditional detethering operations, Kokubun et al. 28 ,29 pioneered a spine-shortening procedure to relieve the longitudinal tension placed on the tethered neural elements without violating the dura. The operation is conducted via a posterior approach and a vertebral osteotomy is performed to facilitate spinal column shortening ( Figs. 2 and 3) . A detailed search of the neurosurgical and orthopedic literature reveals that posterior vertebral column subtraction osteotomy (PVCSO) has been used in 18 patients with TCS since its initial description. In this review, we provide an analysis of the relevant clinical characteristics, operative details, and postoperative outcomes in these patients and assess the role of PVCSO in the treatment of primary and recurrent TCS.
Methods
A PubMed (National Library of Medicine) search was performed to identify all articles pertaining to the use of spinal column shortening for the treatment of primary or recurrent lumbosacral TCS. Surgical series describing neurological outcomes were analyzed in detail and reference lists were reviewed for additional articles not identified in the original PubMed search. In the event that patient populations overlapped, 28, 51 the series with the larger cohort of patients was selected for further review. Pertinent clinical characteristics extracted from each report included patient age and sex, presenting neurological complaints, etiology of TCS, additional spinal pathology, and prior corrective procedures. Regarding operative data and postoperative outcomes, osteotomy level, length of spinal column shortening, duration of follow-up, recovered neurological functions, and residual neurological deficits were recorded.
Articles originally published in Japanese were translated to English by a professional translation service.
Surgical Technique and Operative Details
The following describes our approach to the PVCSO for a patient with primary or recurrent TCS without additional spinal column pathology. 16 For optimal reduction of tension on the conus medullaris, filum terminale, and spinal cord, PVCSO is performed in the lower thoracic or upper lumbar levels. 12 The specific osteotomy level, extent of bony resection, and degree of instrumentation should be determined on a patient-by-patient basis.
The patient is placed in the prone position on a Jackson Spinal Table. Neurophysiological monitoring, including somatosensory evoked potentials, motor evoked potentials, and free-run electromyography, is performed. 42 A midline incision is made to expose the spine 2 levels rostral and 2 levels caudal to the planned PVCSO site (that is, T-12). We prefer to perform the osteotomy at the thoracolumbar junction. With the need to stabilize the spine 2 levels above and below to achieve immediate postoperative spinal stability for early mobilization, a T-11 or T-12 osteotomy allows one to spare more mobile segments in the lumbar spine. In addition, the regional spinal profile is neutral on both the sagittal and coronal plane. Therefore, a single-plane correctional maneuver to shorten the spinal column can avoid potential long-term decompensation of global spinal balance.
Following wide exposure of the T-12 segment, bilateral pedicle screws are implanted at T-10, T-11, L-1, and L-2, allowing for the placement of a relatively short yet biomechanically stable construct. To expose the lateral T-12 VB, the bilateral rib complexes, including the rib head and neck, and bilateral transverse processes at T-12 are removed (Fig. 2) . Careful subperiosteal dissection along the lateral VB and lateral T-12 pedicle is performed until the anterior VB is visualized. A T11-12 discectomy is then carried out posterolaterally and the T-12 pedicles are removed entirely using a combination of rongeur and high-speed drilling. Prior to initiating the osteotomy, temporary rods are placed onto the pedicle screws to prevent translation of the spine while the posterior VB is osteotomized (Fig. 3 ). An approximate 20-mm T-12 VB osteotomy is created using a high-speed drill, beginning with the lateral walls and then moving in a posteroanterior fashion. The anterior VB wall is resected to the anterior longitudinal ligament, which is preserved; the posterior longitudinal ligament is sacrificed during removal of the posterior VB wall. Throughout the procedure, care is taken to avoid placing any unnecessary pressure on the thecal sac to prevent iatrogenic spinal cord injury.
Following completion of the VB resection, the temporary rods are replaced with 2 short segmental rods connected in parallel with domino connectors to facilitate safe, incremental closure of the osteotomy. Fusion across the 2 surfaces of the osteotomy can be achieved by placement of local autograft or iliac crest autograft. Alternatively, rhBMP-2 can be used to enhance bone fusion. 8, 9, 46 The use of rhBMP-2 is an off-label application of this product. However, clinical studies have shown that rhBMP-2 results in high rate of fusion in multisegment spinal fusions for spinal deformity without the morbidity associated with iliac crest autograft harvest. Nevertheless, the cost and complications related to the rhBMP-2, including heterotopic bone growth and osteolysis, must be taken into account. The cephalad rod is secured onto the T-10 and T11 pedicle screws while the caudal rod is secured onto the L-1 and L-2 screws. The approximate 20-mm gap created by the T11-12 discectomy and T-12 osteotomy is now closed with serial compression through the domino connectors; temporary rods are replaced with permanent rods once final spinal column alignment is achieved (Fig. 3) . Posterolateral arthrodesis is performed and the wound is closed in anatomical layers.
Many patients in whom PVCSO is indicated have undergone prior spinal column operations. In these cases, the PVCSO should be performed away from the prior operative site, as scar formation and arachnoid adhesions can place the neural structures at risk for injury during spinal shortening. 40 
Tethered Cord Syndrome: Pathophysiology, Clinical Presentation, and Treatment Options
Tethered cord syndrome is multifold in its etiology, yet what constitutes a tethered spinal cord has been the subject of much debate due in part to a limited understanding of the underlying pathophysiology. When Hoffman et al. 15 published their account of 31 cases of TCS in 1976, only those patients with radiographic evidence of a low-lying conus medullaris secondary to a thick filum terminale were included in the analysis. 1, 58 Patients with lipomyelomeningoceles, myelomeningoceles, diastematomyelia, or other space-occupying lesions of the lumbosacral region were excluded from the study, despite Lichtenstein's observations in 1940 that lumbosacral masses can pathologically tether the caudal spinal cord. 58 In 1981, Yamada et al. 61 established experimentally in human and animal models of TCS that excessive stretching of the spinal neural elements impairs normal neuronal oxidative metabolism and overall electrophysiological functioning, therein providing a metabolic cause to a functional neurological effect. Their investigations further demonstrated that surgical release of the tethered neural structures restores oxidative metabolism with subsequent restoration of neurological function, a finding neurosurgeons had observed for many years despite little knowledge of the molecular pathophysiology. 55 With a greater understanding of the subtle molecular defects present in TCS, the definition of a tethered spinal cord would gradually come to encompass the spectrum of lesions initially excluded from Hoffman and colleagues' analysis. 1, 56, 59 The presenting signs and symptoms of TCS are almost as diverse as its causes, and although commonalities exist, the clinical presentation varies by age. 41, 60 Infants and children classically present with foot and spinal deformity and often have cutaneous manifestations of spinal dysraphism, such as lumbosacral capillary hemangiomas or tufts of hair. Urinary symptoms are common and manifest as excessive dribbling and delayed toilet training. Lower-extremity motor deficits typically result in gait abnormalities. Neurological symptoms are aggravated by growth spurts, which place excessive tension on the tethered spinal cord. 7, 42 In contrast to children, adults present more frequently with complaints of pain in the low back, anus and perineum, and lower extremities. Motor deficits manifest as pure lower-extremity weakness. As with children, urological symptoms are common and frequency, urgency, and incontinence are typical complaints. Factors that precipitate symptom onset include trauma, disc herniation, lumbar spondylosis, spinal canal stenosis, and excessive lumbar flexion or extension. 13, 20, 41, 57 In children and adults, surgical management of TCS is warranted at the first sign of neurological impairment. 31 The classic operation is a detethering procedure, in which the tethered neural structures are meticulously freed from their attachments, and this is followed by correction or removal of any associated pathology. In most cases, the filum terminale is severed or pathological adhesions around the distal spinal cord are detethered to reduce tension on the caudal spinal cord and associated neural elements. To avoid postoperative CSF leakage and pseudomeningocele formation, care is taken to close the dura in a watertight fashion. 1, 31, 32 Most patients experience an improvement in their preoperative neurological symptoms following firsttime release; however, favorable recoveries decline with additional release operations. 33, 53 In severe cases of recurrent TCS, Blount et al. 4 have advocated for complete spinal cord transection as a definitive measure of preserving more rostral neurological function. They have argued that traditional detethering procedures leave the freed neural structures approximated too closely to the incised dura, which allows for repeated retethering during the normal wound healing process. The procedure is reserved for selected cases in which the spinal cord and filum terminale are nonfunctional and in which the main goal of surgery is not to restore neurological function but to prevent further decline. Despite these available surgical options, a 
Posterior Vertebral Column Subtraction Osteotomy
Spine-shortening procedures were first used for the correction of various deformities of the spinal column. 3, 5, 22, [47] [48] [49] [50] The operations were initially conducted via dual anterior and posterior approaches and consisted of either wedge osteotomies or VB resection for spinal column shortening. Following critical advances in the technology of spine instrumentation, a single posterior approach for spine-shortening operations was developed. 29, [47] [48] [49] Classic indications for spinal column shortening include severe scoliosis, kyphosis, and VB fractures. 19, 23, 29, 43 In 1995, Kokubun 28 described the use of a spine-shortening procedure performed via a posterior approach for the treatment of TCS in 2 patients. The operation was conducted in lieu of a traditional detethering procedure as a means of relieving pathological tension on the tethered spinal cord and nerve roots, and was the first report of an entirely extradural procedure for TCS treatment. Although only 1 patient experienced complete neurological recovery, the initial results were promising and provided cause for further investigation into this novel technique. Subsequently, using a cadaveric model of TCS, Grande et al. 12 demonstrated that greater than 90% of the neural elements require release by traditional surgical detethering to achieve the same decrease in tension on the spinal cord, nerve roots, and filum terminale as a 15-25-mm VCSO at the thoracolumbar junction. Since efficient release of the tension placed on the tethered neural structures is necessary for improved oxidative metabolism and electrophysiological functioning, 61 PVCSO may be a preferable alternative to traditional detethering operations (Figs. 4 and 5) . Table 1 summarizes the relevant clinical characteristics of the patients described in previously published case reports that provided significant clinical data. There are currently a total of 18 patients who underwent PVCSO for TCS treatment with significant clinical data provided in the previous publications. 16, 22, 28, 34, 37, 39, 51, 52 The mean age at the time of surgery was 40 years (range 12-57 years). Prior to PVCSO, 5 patients (28%) underwent traditional detethering operations and 5 patients (28%) underwent excision of the lumbosacral mass. Lumbosacral lipomyelomeningocele (61%) and lumbosacral lipoma (28%) were the most common causes of TCS. One patient (6%) had a VB fracture and 1 patient (6%) suffered from severe kyphoscoliosis with an intramedullary syrinx in addition to a tethered spinal cord. Lumbosacral spina bifida was identified in 5 patients (28%). Presenting neurological symptoms included urinary dysfunction (94%), lower-extremity sensory disturbances (89%), lower-extremity motor disturbances and/or gait abnormalities (78%), low-back and/or lower-extremity pain (72%), bowel incontinence (11%), and sexual dysfunction (11%). In 2 instances, the decision to perform PVCSO was motivated by marked worsening of the patient's neurological status following a traditional detethering procedure; 34, 39 in these cases, the duration to PVCSO was 3 months. In these patients, the primary goal of PVCSO was reportedly to prevent further neurological deterioration rather than to offer functional recovery.
Case Series and Outcome Data
Pertinent operative data and postoperative outcomes are summarized in Table 2 . No intraoperative or immediate postoperative complications were reported. The vertebral osteotomy was performed at L-1 in 14 patients (78%), at T-12 in 2 patients (11%), and at T-9 and L-2 in 1 patient each (6%). The length of spinal column shortening was reported for 16 patients (mean length 20.5 mm). The mean follow-up duration was 3 years (range 6 months-10 years). Urinary dysfunction (17 cases) was the most common residual deficit, as only 3 patients (18%) noted a full recovery of function. Two (12%) of 17 patients with urological symptoms reported improvements, although deficits remained at the time of last follow-up. Twelve (86%) of 16 patients with lower-extremity motor dysfunction improved and 8 (50%) noted complete resolution of preoperative lower-extremity sensory symptoms. Nine patients (75%) reported immediate low-back or lower-extremity pain relief following PVCSO. Two patients (100%) reported improved sexual functioning, although only 1 regained complete erectile capabilities. Two patients (11%) experienced little symptomatic or functional benefit from PVCSO. In these cases, however, the main aim of surgery was to prevent further worsening of the neurological condition, as each had experienced new-onset neurological dysfunction following a detethering operation shortly before undergoing spinal column shortening. Where reported, complete bone union at the osteotomy site was noted in all cases at the time of last follow-up. 16 ,22,28,37,39,51
Discussion
The surgical management of both primary and recurrent lumbosacral TCS is complex, yet without intervention patients will suffer progressive neurological, orthopedic, and urological decline. 1, 21, 33 Several studies have evaluated the symptomatic and functional outcome of adults undergoing detethering procedures for primary lumbosacral TCS and collectively indicate a 38.5%-61% improvement in urinary symptoms, a 44%-70% improvement in weakness/motor disturbances, and an 81%-91% improvement in pain following surgical detethering. 11, 17, 20, 31, 41 Despite these encouraging outcomes, a reported 5%-50% of patients eventually experience symptomatic retethering, and patients who undergo multiple detethering operations do not share this same degree of success. 31, 33 Our review of the available outcome data in patients who have undergone PVCSO indicate that 28% exhibited improved urological symptoms, 86% recovered complete motor functioning, and 75% were relieved of debilitating back or lower-extremity pain. Although many factors preclude a direct comparison of the symptomatic and functional outcomes following traditional surgical detethering compared with PVCSO for TCS treatment, the outcomes, grossly, are similar. Regardless, we believe that the principal benefits of PVCSO over detethering operations will be in preserving the symptomatic and functional neurological improvements with lasting results and potentially obviating the need for future reoperations. However, longer follow-up results are needed from the PVCSO series to support this belief.
In the treatment of TCS, there are several advantages of PVCSO over detethering operations. First, direct manipulation of the neural structures is not required. Because traditional detethering procedures mandate careful dissection of the tethered spinal cord and affected neural elements away from the sites of adhesion, the risk of direct neurological injury is high. Operations for recurrent TCS may be additionally complicated by extensive scar formation and arachnoid adhesions, 30 further elevating the likelihood of iatrogenic neurological injury. Second, because PVCSO is an entirely extradural operation, the risks associated with postoperative CSF leakage and pseudomeningocele formation can be largely avoided. Third, PVCSO reduces traction on the affected neural elements indirectly (Fig. 5) . Given adequate bone union and a stable instrumented construct, the beneficial effects of spinal column shortening should remain permanent. As a result, patients may be able to expect sustained improvements in their neurological symptoms, and the risks and costs associated with reoperations may be avoided. These advantages are particularly relevant in patients who have undergone multiple intradural detethering procedures without success. It is our belief and practice that patients are considered for PVCSO only in recurrent cases of TCS without local mass effects or findings that are amendable to standard surgical detethering procedures. Nevertheless, our current literature review has shown that, in the Japanese literature, 5 patients have undergone primary PVCSO treatment for lumbosacral lipoma or lipomyelomeningocele with favorable outcomes. Future clinical studies with longer clinical follow-up periods will be necessary to determine if PVCSO can be as effective as the traditional detethering surgery in the primary surgical treatment for patients with TCS.
Despite the appeal of PVCSO for the treatment of primary and recurrent TCS, there are several theoretical disadvantages. First, as a result of extensive dissection and spinal manipulation, iatrogenic neurological injury may * B = bowel incontinence; E = erectile/sexual dysfunction; M = motor disturbance; NA = not available; P = pain; S = sensory disturbance; U = urinary dysfunction. † The reported duration indicates the approximate time from symptom onset to PVCSO; the actual duration and degree of neurological dysfunction were variable in patients who underwent prior procedures. ‡ All cases were reportedly secondary to low-lying conus medullaris syndrome rather than a documented thickened filum terminale. ¶ Interval to PVCSO refers to the time period between the patient's last operation and PVCSO.
arise from excessive nerve root traction, dural violation, or exacerbation of prior spinal deformities. 18, 24 In an analysis of the risk of neurological injury following lumbar pedicle subtraction osteotomy, reported by Buchowski et al., 6 3% of patients experienced permanent new-onset neurological deficits. Second, because the osteotomy involves all 3 spinal columns, the spine is highly unstable following PVCSO, and translation, subluxation, or misalignment can occur if the gap closure is inadequate, or if pseudarthrosis develops. Despite the use of an instrumented construct for spinal stabilization, pseudarthrosis has been found in 17%-24% of cases involving multisegmental, instrumented fusion. [25] [26] [27] Such complications increase the risk of instrumentation failure, neurological injury, spinal deformity, and chronic back pain. The complication rate associated with a similar technique of pedicle subtraction osteotomy in deformity revisions can be as high as 50%, but much of those complications are related to medical complications resulting from performing high-risk complex spinal surgeries in a more elderly population. Third, instrumented fusion of the spinal column is required with PVCSO. To ensure biomechanical stability, our protocol is to provide fixation 2 levels rostral and caudal to the osteotomy, necessitating a 4-level fusion. A multisegmented, instrumented fusion predisposes the patient to future disease in adjacent segments. 36 Fourth, vertebral column resection requires extensive paraspinal dissection and the amount of perioperative blood loss is not trivial. This can be minimized with careful subperiosteal dissection along the VB wall, which reduces injury to segmental vessels. Despite these potential drawbacks and the inherent technical demands of the operation, the procedure can be performed safely and with acceptable surgical risks at experienced centers.
Our analysis of data obtained in 18 patients reported on in the literature indicates that PVCSO is a viable alternative to traditional detethering operations for the management of primary and recurrent TCS. Future outcome studies with larger sample sizes and long-term follow-up are needed to further clarify the risks and benefits of the procedure and to identify specific patient groups most likely to benefit from PVCSO.
Conclusions
Tethered cord syndrome is a progressively debilitating neurological condition caused by abnormal longitudinal traction on the caudal spinal cord. The classic treatment is surgical detethering, although rates of symptomatic retethering range from 5%-50%. With subsequent operations, surgical complications increase while favorable neurological outcomes decrease. The present analysis indicates that PVCSO is a safe and effective alternative to traditional detethering operations for the treatment of primary and recurrent TCS. Not only does the procedure avoid the risks inherent in any intradural operation, but cadaveric studies also indicate that extensive surgical detethering is necessary to achieve results similar to those from a 15-25-mm thoracolumbar PVCSO. Because the use of PVCSO for TCS treatment is in its infancy, future studies with a larger number of patients and longer follow- up periods are needed to verify its efficacy and identify patients most likely to benefit from this novel approach.
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